These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25646419)
21. Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sugata K; Yasunaga J; Miura M; Akari H; Utsunomiya A; Nosaka K; Watanabe Y; Suzushima H; Koh KR; Nakagawa M; Kohara M; Matsuoka M Sci Rep; 2016 Jun; 6():27150. PubMed ID: 27250643 [TBL] [Abstract][Full Text] [Related]
22. The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2. Casoli C; De Lerma Barbaro A; Pilotti E; Bertazzoni U; Tosi G; Accolla RS Blood; 2004 Feb; 103(3):995-1001. PubMed ID: 14525769 [TBL] [Abstract][Full Text] [Related]
23. Constitutive cytokine release by simian T-cell lymphotrophic virus type I (STLV-I) and human T-cell lymphotrophic virus types I/II (HTLV-I/II) transformed cell lines. Lazo A; Bailer RT J Med Primatol; 1996 Aug; 25(4):257-66. PubMed ID: 8906604 [TBL] [Abstract][Full Text] [Related]
24. HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells. Olagnier D; Sze A; Bel Hadj S; Chiang C; Steel C; Han X; Routy JP; Lin R; Hiscott J; van Grevenynghe J PLoS Pathog; 2014 Dec; 10(12):e1004575. PubMed ID: 25521510 [TBL] [Abstract][Full Text] [Related]
25. HTLV-1 Proliferation after CD8 Nakamura-Hoshi M; Nomura T; Nishizawa M; Hau TTT; Yamamoto H; Okazaki M; Ishii H; Yonemitsu K; Suzaki Y; Ami Y; Matano T Microbiol Spectr; 2023 Aug; 11(4):e0151823. PubMed ID: 37367230 [TBL] [Abstract][Full Text] [Related]
26. Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1. Jiang S; Inada T; Tanaka M; Furuta RA; Shingu K; Fujisawa J Retrovirology; 2009 Aug; 6():73. PubMed ID: 19664292 [TBL] [Abstract][Full Text] [Related]
27. Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma. Zhan Y; Feng J; Lu J; Xu L; Wang W; Fan S J Clin Pathol; 2019 Jun; 72(6):425-430. PubMed ID: 30918012 [TBL] [Abstract][Full Text] [Related]
28. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas. Tiemessen MM; Baert MR; Schonewille T; Brugman MH; Famili F; Salvatori DC; Meijerink JP; Ozbek U; Clevers H; van Dongen JJ; Staal FJ PLoS Biol; 2012; 10(11):e1001430. PubMed ID: 23185135 [TBL] [Abstract][Full Text] [Related]
29. Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells. Berga-Bolaños R; Zhu WS; Steinke FC; Xue HH; Sen JM Mol Immunol; 2015 Dec; 68(2 Pt B):484-9. PubMed ID: 26490636 [TBL] [Abstract][Full Text] [Related]
30. Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus. Mori N; Prager D Leuk Lymphoma; 1997 Aug; 26(5-6):421-33. PubMed ID: 9389351 [TBL] [Abstract][Full Text] [Related]
31. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors. Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748 [TBL] [Abstract][Full Text] [Related]
32. TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases. Yang BH; Wang K; Wan S; Liang Y; Yuan X; Dong Y; Cho S; Xu W; Jepsen K; Feng GS; Lu LF; Xue HH; Fu W Cell Rep; 2019 Jun; 27(12):3629-3645.e6. PubMed ID: 31216480 [TBL] [Abstract][Full Text] [Related]
33. From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells. Steinke FC; Xue HH Immunol Res; 2014 Aug; 59(1-3):45-55. PubMed ID: 24847765 [TBL] [Abstract][Full Text] [Related]
34. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. Xing S; Gai K; Li X; Shao P; Zeng Z; Zhao X; Zhao X; Chen X; Paradee WJ; Meyerholz DK; Peng W; Xue HH J Exp Med; 2019 Apr; 216(4):847-866. PubMed ID: 30837262 [TBL] [Abstract][Full Text] [Related]
35. HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice. Villaudy J; Wencker M; Gadot N; Gillet NA; Scoazec JY; Gazzolo L; Manz MG; Bangham CR; Dodon MD PLoS Pathog; 2011 Sep; 7(9):e1002231. PubMed ID: 21909275 [TBL] [Abstract][Full Text] [Related]
36. Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity. Xing S; Li F; Zeng Z; Zhao Y; Yu S; Shan Q; Li Y; Phillips FC; Maina PK; Qi HH; Liu C; Zhu J; Pope RM; Musselman CA; Zeng C; Peng W; Xue HH Nat Immunol; 2016 Jun; 17(6):695-703. PubMed ID: 27111144 [TBL] [Abstract][Full Text] [Related]
37. Differential expression of LEF1/TCFs family members in colonic carcinogenesis. Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921 [TBL] [Abstract][Full Text] [Related]
38. Tcf1 and Lef1 provide constant supervision to mature CD8 Shan Q; Li X; Chen X; Zeng Z; Zhu S; Gai K; Peng W; Xue HH Nat Commun; 2021 Oct; 12(1):5863. PubMed ID: 34615872 [TBL] [Abstract][Full Text] [Related]
39. Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker. Kinjo T; Ham-Terhune J; Peloponese JM; Jeang KT J Virol; 2010 May; 84(10):5431-7. PubMed ID: 20219913 [TBL] [Abstract][Full Text] [Related]
40. Howard Temin memorial lectureship. Molecular biology of HTLV-1: deregulation of host cell gene expression and cell cycle. Yoshida M Leukemia; 1997 Jan; 11(1):14-5. PubMed ID: 9001412 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]